The therapeutic effect of gelatin and dextran plasma substitutes following a standard experimental hemorrhagic shock.
D000136:Acid-Base Equilibrium / Q000187:drug effects; D000138:Acidosis / Q000628:therapy; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001803:Blood Transfusion; D001810:Blood Volume; D001835:Body Weight; D003102:Colloids; D003911:Dextrans / Q000627:therapeutic use; D004195:Disease Models, Animal; D005780:Gelatin / Q000627:therapeutic use*; D006400:Hematocrit; D006863:Hydrogen-Ion Concentration; D007773:Lactates / Q000097:blood; D010952:Plasma Substitutes / Q000627:therapeutic use*; D011817:Rabbits; D012771:Shock, Hemorrhagic / Q000628:therapy*
D003102:Colloids; D003911:Dextrans; D007773:Lactates; D010952:Plasma Substitutes; D005780:Gelatin